Medical Journals

Hybrid Antibacterials. Dna Polymerase-topoisomerase Inhibitors.

Authors:
  • Zhi Chengxin
  • Long Zheng-Yu
  • Manikowski Andrzej
  • Comstock Jeanne
  • Xu Wei-Chu
  • Brown Neal C
  • Tarantino Paul M
  • Holm Karsten A
  • Dix Edward J
  • Wright George E
  • Barnes Marjorie H
  • Butler Michelle M
  • Foster Kimberly A
  • LaMarr William A
  • Bachand Benoit
  • Bethell Richard
  • Cadilhac Caroline
  • Charron Sylvie
  • Lamothe Serge
  • Motorina Irina
  • Storer Richard

From: GLSynthesis Inc., One Innovation Drive, Worcester, Massachusetts 01605, USA.

Journal of medicinal chemistry

  • Publish Date: Feb 2006
  • ISSN: 0022-2623
  • Volume: 49
  • Issue: 4
  • Pages: 1455-65
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zhi Chengxin, Long Zheng-Yu, Manikowski Andrzej, et al. Hybrid Antibacterials. Dna Polymerase-topoisomerase Inhibitors.. J. Med. Chem. Feb 2006;49:1455-65

Abstract

Novel Gram-positive (Gram+) antibacterial compounds consisting of a DNA polymerase IIIC (pol IIIC) inhibitor covalently connected to a topoisomerase/gyrase inhibitor are described. Specifically, 3-substituted 6-(3-ethyl-4-methylanilino)uracils (EMAUs) in which the 3-substituent is a fluoroquinolone moiety (FQ) connected by various linkers were synthesized. The resulting “AU-FQ” hybrid compounds were significantly more potent than the parent EMAU compounds as inhibitors of pol IIIC and were up to 64-fold more potent as antibacterials in vitro against Gram+ bacteria. The hybrids inhibited the FQ targets, topoisomerase IV and gyrase, with potencies similar to norfloxacin but 10-fold lower than newer agents, for example, ciprofloxacin and sparfloxacin. Representative hybrids protected mice from lethal Staphylococcus aureus infection after intravenous dosing, and one compound showed protective effect against several antibiotic-sensitive and -resistant Gram+ infections in mice. The AU-FQ hybrids are a promising new family of antibacterials for treatment of antibiotic-resistant Gram+ infections.

Mesh Headings (Keywords): Acute Toxicity Tests, Aniline Compounds, Animals, Anti-Bacterial Agents, DNA Gyrase, DNA Polymerase III, Drug Resistance, Bacterial, Gram-Positive Bacteria, Male, Mice, Staphylococcal Infections, Staphylococcus aureus, Structure-Activity Relationship, Uracil


Check for Full Text / PubMed Unique Identifier (PMID): 16480282


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.